• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯并呋喃核心抑制剂与丙型肝炎病毒 NS5B 聚合酶不同基因型的独特结合模式:分子模拟研究。

Distinct Characteristic Binding Modes of Benzofuran Core Inhibitors to Diverse Genotypes of Hepatitis C Virus NS5B Polymerase: A Molecular Simulation Study.

机构信息

School of Medical Engineering, Xinxiang Medical University, Xinxiang 453003, China.

Henan International Joint Laboratory of Neural Information Analysis and Drug Intelligent Design, Xinxiang 453003, China.

出版信息

Int J Mol Sci. 2024 Jul 23;25(15):8028. doi: 10.3390/ijms25158028.

DOI:10.3390/ijms25158028
PMID:39125602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11311972/
Abstract

The benzofuran core inhibitors , , , compound , and compound exhibit good pan-genotypic activity against various genotypes of NS5B polymerase. To elucidate their mechanism of action, multiple molecular simulation methods were used to investigate the complex systems of these inhibitors binding to GT, , , and NS5B polymerases. The calculation results indicated that these five inhibitors can not only interact with the residues in the palm II subdomain of NS5B polymerase, but also with the residues in the palm I subdomain or the palm I/III overlap region. Interestingly, the binding of inhibitors with longer substituents at the C5 position (, , compound , and compound ) to the GT and NS5B polymerases exhibits different binding patterns compared to the binding to the GT and NS5B polymerases. The interactions between the para-fluorophenyl groups at the C2 positions of the inhibitors and the residues at the binding pockets, together with the interactions between the substituents at the C5 positions and the residues at the reverse β-fold (residues 441-456), play a key role in recognition and the induction of the binding. The relevant studies could provide valuable information for further research and development of novel anti-HCV benzofuran core pan-genotypic inhibitors.

摘要

苯并呋喃核心抑制剂、、、化合物和化合物对各种基因型的 NS5B 聚合酶均表现出良好的泛基因型活性。为了阐明它们的作用机制,采用多种分子模拟方法研究了这些抑制剂与 GT、、、和 NS5B 聚合酶的复合物体系。计算结果表明,这五种抑制剂不仅可以与 NS5B 聚合酶的 palm II 亚结构域中的残基相互作用,还可以与 palm I 亚结构域或 palm I/III 重叠区域中的残基相互作用。有趣的是,C5 位取代基较长的抑制剂(、、化合物和化合物)与 GT 和 NS5B 聚合酶的结合与与 GT 和 NS5B 聚合酶的结合表现出不同的结合模式。抑制剂 C2 位的对氟苯基与结合口袋中残基之间的相互作用,以及 C5 位取代基与反向β折叠(残基 441-456)中残基之间的相互作用,在识别和诱导结合中起着关键作用。相关研究可为进一步研究和开发新型抗 HCV 苯并呋喃核心泛基因型抑制剂提供有价值的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/3de0bea1da69/ijms-25-08028-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/5da5f7989bf1/ijms-25-08028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/b771ad21d7c9/ijms-25-08028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/72d96ef51315/ijms-25-08028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/a784a5060ee2/ijms-25-08028-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/c84a95964940/ijms-25-08028-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/86edfbe8de11/ijms-25-08028-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/1c0dc4e8b825/ijms-25-08028-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/ed39447acb6a/ijms-25-08028-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/9098b02abfc7/ijms-25-08028-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/d2688a74a3ca/ijms-25-08028-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/50219c941357/ijms-25-08028-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/70ee724f7164/ijms-25-08028-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/ab6817d7373c/ijms-25-08028-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/935537e55f0c/ijms-25-08028-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/75be0b8f9163/ijms-25-08028-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/4f33b9407581/ijms-25-08028-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/dba6ed571e98/ijms-25-08028-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/f05336ecb190/ijms-25-08028-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/7427d87b1485/ijms-25-08028-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/35de5f582f3d/ijms-25-08028-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/bd28100c18ae/ijms-25-08028-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/c78204489895/ijms-25-08028-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/0d63c6d7f374/ijms-25-08028-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/b80613c62e3d/ijms-25-08028-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/de9fad805d3b/ijms-25-08028-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/93d104fe5ecd/ijms-25-08028-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/3de0bea1da69/ijms-25-08028-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/5da5f7989bf1/ijms-25-08028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/b771ad21d7c9/ijms-25-08028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/72d96ef51315/ijms-25-08028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/a784a5060ee2/ijms-25-08028-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/c84a95964940/ijms-25-08028-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/86edfbe8de11/ijms-25-08028-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/1c0dc4e8b825/ijms-25-08028-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/ed39447acb6a/ijms-25-08028-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/9098b02abfc7/ijms-25-08028-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/d2688a74a3ca/ijms-25-08028-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/50219c941357/ijms-25-08028-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/70ee724f7164/ijms-25-08028-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/ab6817d7373c/ijms-25-08028-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/935537e55f0c/ijms-25-08028-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/75be0b8f9163/ijms-25-08028-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/4f33b9407581/ijms-25-08028-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/dba6ed571e98/ijms-25-08028-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/f05336ecb190/ijms-25-08028-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/7427d87b1485/ijms-25-08028-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/35de5f582f3d/ijms-25-08028-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/bd28100c18ae/ijms-25-08028-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/c78204489895/ijms-25-08028-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/0d63c6d7f374/ijms-25-08028-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/b80613c62e3d/ijms-25-08028-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/de9fad805d3b/ijms-25-08028-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/93d104fe5ecd/ijms-25-08028-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a909/11311972/3de0bea1da69/ijms-25-08028-g027.jpg

相似文献

1
Distinct Characteristic Binding Modes of Benzofuran Core Inhibitors to Diverse Genotypes of Hepatitis C Virus NS5B Polymerase: A Molecular Simulation Study.苯并呋喃核心抑制剂与丙型肝炎病毒 NS5B 聚合酶不同基因型的独特结合模式:分子模拟研究。
Int J Mol Sci. 2024 Jul 23;25(15):8028. doi: 10.3390/ijms25158028.
2
Discovery of substituted N-phenylbenzenesulphonamides as a novel class of non-nucleoside hepatitis C virus polymerase inhibitors.发现取代的 N-苯基苯磺酰胺类化合物作为一类新型非核苷丙型肝炎病毒聚合酶抑制剂。
Antiviral Res. 2012 Aug;95(2):182-91. doi: 10.1016/j.antiviral.2012.04.008. Epub 2012 May 10.
3
Combined 3D-QSAR, molecular docking, molecular dynamics simulation, and binding free energy calculation studies on the 5-hydroxy-2H-pyridazin-3-one derivatives as HCV NS5B polymerase inhibitors.基于 HCV NS5B 聚合酶抑制剂的 5-羟基-2H-哒嗪-3-酮衍生物的三维定量构效关系、分子对接、分子动力学模拟和结合自由能计算研究的综合报告。
Chem Biol Drug Des. 2014 Jan;83(1):89-105. doi: 10.1111/cbdd.12203. Epub 2013 Oct 4.
4
Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors.构建基因间嵌合复制子以确定丙型肝炎病毒聚合酶抑制剂的广谱抗病毒活性。
Antimicrob Agents Chemother. 2008 Oct;52(10):3523-31. doi: 10.1128/AAC.00533-08. Epub 2008 Aug 11.
5
Regulation of NS5B Polymerase Activity of Hepatitis C Virus by Target Specific Phytotherapeutics: An In-Silico Molecular Dynamics Approach.靶向特异性植物疗法对丙型肝炎病毒NS5B聚合酶活性的调控:一种计算机模拟分子动力学方法
Cell Biochem Biophys. 2024 Sep;82(3):2473-2492. doi: 10.1007/s12013-024-01359-w. Epub 2024 Jul 23.
6
Screening of hepatitis C NS5B polymerase inhibitors containing benzothiadiazine core: a steered molecular dynamics.含苯并噻二嗪核心的丙型肝炎NS5B聚合酶抑制剂的筛选:引导分子动力学
J Biomol Struct Dyn. 2017 Jun;35(8):1743-1757. doi: 10.1080/07391102.2016.1193444. Epub 2016 Jun 27.
7
Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus.丙型肝炎病毒非核苷类聚合酶抑制剂的慢结合抑制作用及耐药机制
J Biol Chem. 2009 Jun 5;284(23):15517-29. doi: 10.1074/jbc.M808889200. Epub 2009 Feb 26.
8
Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.多电子药效团模型、3D-QSAR 和丙型肝炎病毒 NS5B 聚合酶抑制剂的高通量虚拟筛选。
J Chem Inf Model. 2014 Feb 24;54(2):539-52. doi: 10.1021/ci400644r. Epub 2014 Feb 5.
9
Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors.多种虚拟筛选方法寻找新型丙型肝炎病毒 RNA 依赖的 RNA 聚合酶抑制剂:基于结构的筛选和分子动力学研究新型多药理学抑制剂。
BMC Bioinformatics. 2012;13 Suppl 17(Suppl 17):S5. doi: 10.1186/1471-2105-13-S17-S5. Epub 2012 Dec 13.
10
Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice.在人源化肝细胞嵌合小鼠中,针对丙型肝炎病毒不同基因型的 NS5A、NS3 和 NS5B 抑制剂联合治疗。
Gut. 2013 Jul;62(7):1055-61. doi: 10.1136/gutjnl-2012-302600. Epub 2013 Jan 15.

引用本文的文献

1
Virtual screening, optimization design, and synthesis analysis of novel benzofuran derivatives as pan-genotypic HCV NS5B polymerase inhibitors using molecular modeling.利用分子建模对新型苯并呋喃衍生物作为泛基因型丙型肝炎病毒NS5B聚合酶抑制剂进行虚拟筛选、优化设计及合成分析。
BMC Chem. 2025 Jul 4;19(1):199. doi: 10.1186/s13065-025-01575-2.

本文引用的文献

1
The roles and mechanism of mA RNA methylation regulators in cancer immunity.mRNA 甲基化调控因子在癌症免疫中的作用和机制。
Biomed Pharmacother. 2023 Jul;163:114839. doi: 10.1016/j.biopha.2023.114839. Epub 2023 May 8.
2
Design Two Novel Tetrahydroquinoline Derivatives against Anticancer Target LSD1 with 3D-QSAR Model and Molecular Simulation.设计两种新型四氢喹啉衍生物对抗 LSD1 抗癌靶点的 3D-QSAR 模型和分子模拟。
Molecules. 2022 Nov 30;27(23):8358. doi: 10.3390/molecules27238358.
3
Progression of Antiviral Agents Targeting Viral Polymerases.
抗病毒药物针对病毒聚合酶的作用机制研究进展。
Molecules. 2022 Oct 29;27(21):7370. doi: 10.3390/molecules27217370.
4
A Closed-Form, Analytical Approximation for Apparent Surface Charge and Electric Field of Molecules.分子表观表面电荷与电场的闭式解析近似
ACS Omega. 2022 Jul 19;7(30):26123-26136. doi: 10.1021/acsomega.2c01484. eCollection 2022 Aug 2.
5
StackHCV: a web-based integrative machine-learning framework for large-scale identification of hepatitis C virus NS5B inhibitors.StackHCV:一种基于网络的集成机器学习框架,用于大规模鉴定丙型肝炎病毒 NS5B 抑制剂。
J Comput Aided Mol Des. 2021 Oct;35(10):1037-1053. doi: 10.1007/s10822-021-00418-1. Epub 2021 Oct 8.
6
Structural basis of the stereoselective formation of the spirooxindole ring in the biosynthesis of citrinadins.结构基础的立体选择性形成的 spirooxindole 环在生物合成 citrinadins。
Nat Commun. 2021 Jul 6;12(1):4158. doi: 10.1038/s41467-021-24421-0.
7
Insight into the drug resistance mechanisms of GS-9669 caused by mutations of HCV NS5B polymerase via molecular simulation.通过分子模拟深入了解丙型肝炎病毒NS5B聚合酶突变导致GS-9669耐药机制
Comput Struct Biotechnol J. 2021 Apr 20;19:2761-2774. doi: 10.1016/j.csbj.2021.04.026. eCollection 2021.
8
HCV virology and diagnosis.丙型肝炎病毒的病毒学与诊断
Clin Res Hepatol Gastroenterol. 2021 May;45(3):101626. doi: 10.1016/j.clinre.2021.101626. Epub 2021 Feb 23.
9
Therapy Implications of Hepatitis C Virus Genetic Diversity.丙型肝炎病毒遗传多样性的治疗意义。
Viruses. 2020 Dec 29;13(1):41. doi: 10.3390/v13010041.
10
Development of a Method for Screening and Genotyping of HCV 1a, 1b, 2, 3, 4, and 6 Genotypes.丙型肝炎病毒1a、1b、2、3、4和6基因型的筛选及基因分型方法的开发
ACS Omega. 2020 May 8;5(19):10794-10799. doi: 10.1021/acsomega.0c00386. eCollection 2020 May 19.